Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28
MRP (INCLUSIVE OF ALL TAX) S.G
Serious hypersensitivity reactions have also been reported during postmarketing use with other GLP-1 receptor agonists
By pursuing a much larger target than diabetes, the company expects to unlock the door to a multibillion-dollar market with nearly a billion potential patients
General BMI Considerations GLP-1 medications are generally indicated for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 or higher) who also have at least one weight-related health condition
It acts on receptors in the hypothalamus and brainstem to promote satiety and reduce food intake
Pharmacists should be aware of the following side effects to properly advise and help patients manage accordingly: Hypoglycaemia consider dose reduction of concomitant medications, particularly sulfonylurea and insulin, to prevent hypoglycaemia if this a concern
US$ 25.70
US$ 27.92
US$ 20.71
US$ 23.15
US$ 29.48
US$ 25.14
